Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/30/23 → 6/30/26 |
Funding
- UCB Biopharma SRL (Belgium): $33,140.00
PD0055: A Dose-blinded Extension Study to Evaluate the Long-term Efficacy, Safety, and Tolerability of UCB0599 in Study Participants with Parkinson's Disease
- Slevin, John (PI)